$11.7M to study new ways to treat pain | Ohio State emissions study

$11.7 million grant to study new ways to treat pain

ST. LOUIS, MO–Scientists at Washington University School of Medicine in St. Louis have received a five-year, $11.7 million grant to study human genes and nerve cells to better understand how cells transmit pain and to find new ways to treat it. Washington University will participate in the Precision Human Pain Network, a project that is part of the NIH’s HEAL (Helping to End Addiction Long-Term) initiative.

U.S. DOT invests $26.5M in Ohio State emissions study

COLUMBUS, OH—With the support of a $26.5 million investment from the U.S. Department of Transportation, The Ohio State University will establish and operate a new testing center to support the deployment of zero-emission and low-emission public transportation buses. Funding for the investment was made possible through the bipartisan Infrastructure Investment and Jobs Act, also called the Bipartisan Infrastructure Law.

Alzheimer’s study at Kansas State awarded $1.95 by NIH

MANHATTAN, KS—A researcher at Kansas State University has been awarded a $1.95 million grant from the NIH to study for an Alzheimer’s study. The five-year study will research the extent to which older adults use previous knowledge to help learn and remember new information, as well as if this ability changes in the early stages of Alzheimer’s.

$7.3M grant to Case Western to study eye health

CLEVELAND, OH—Case Western Reserve University has been awarded a five-year, $7.3 million grant from the NIH to identify new technology, methods, and models to study the impact of inflammation and pain on eye health, specifically the surface. The research will involve a multidisciplinary team from CWRU and Cleveland Clinic with expertise in such areas as advanced 3D microscopy, neuroscience, pain, immunology, spatial statistics and machine/deep learning, among other areas.